投资者起诉 West Pharmaceutical Services 因误导性陈述而进行证券欺诈，导致股票下跌 38%。 Investors sue West Pharmaceutical Services for securities fraud over misleading statements, leading to a 38% stock drop.

多个律师事务所正在对West Pharmicals Services Inc.(WST)提起集体诉讼诉讼,指控因关于客户需求、产品利润率和重组风险的误导性言论导致证券欺诈。 Multiple law firms are filing class action lawsuits against West Pharmaceutical Services, Inc. (WST), alleging securities fraud due to misleading statements about customer demand, product profitability, and restructuring risks. 在WST宣布预测不可靠后,这些诉讼导致其存量下降38.2%。 The lawsuits follow WST's announcement of weak forecasts, causing its stock to drop 38.2%. 2023年2月16日至2025年2月12日期间输钱的投资者可以在2025年7月7日前与律师事务所联系, Investors who lost money between February 16, 2023, and February 12, 2025, can join the lawsuit by contacting the law firms by July 7, 2025.